Global /South Korea /Financial Services /Financial Conglomerates /359090
chevron_leftBack
C&R Research Inc. logo

C&R Research Inc.

359090
KRX: 359090 Delayed
777KRW -0.3%
0.5091 USD
As of 11 June 2026, C&R Research Inc. has a market cap of $29.26M USD, ranking #34397 globally and #2134 in South Korea. It ranks #3613 in the Financial Services sector, and #583 in the Financial Conglomerates industry.
Global Rank
34397
Country Rank
2134
Sector Rank
3613
Industry Rank
583
Key Stats
Market Cap
$29.26MUSD
44.65B KRW
Enterprise Value
$26.49MUSD
40.44B KRW
Revenue (TTM)
$42.58MUSD
64.98B KRW
EBITDA (TTM)
$1.66MUSD
2.53B KRW
Net Income (TTM)
$1.69MUSD
2.59B KRW
EBITDA Margin
3.9%
Profit Margin
4%
PE Ratio
17.3
PS Ratio
0.7
PB Ratio
0.9
EV/EBITDA
19.9
Company Profile
Country (HQ)
Sector
Financial Services
Industry
Financial Conglomerates
CEO
Moontae Yoon open_in_new
Employees
510
Founded
1997
Website
cnrres.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.3% -3.5% -4% -12% -19% -26%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
359090
(주)씨엔알리서치 Ordinary Shares
ISIN: KR7359090008
Shares Out.:
57.47M1 Shares Float: 21.047M2
TV:
SA:
YF:
GF:
BA:
MS:
777 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About C&R Research Inc.

C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company’s therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.The company was founded in 1997 and is based in Seoul, South Korea.

Similar Companies

Industry: Financial Conglomerates (South Korea)
Name
Market Cap diff.
PE
402340
$71.72B
109.46T KRW
245K%
12.5
034730
$15.18B
23.17T KRW
52K%
183.9
004800
$2.46B
3.75T KRW
8K%
11.4
$778.86M
1.19T KRW
3K%
-
368770
$504.49M
769.95B KRW
2K%
83.2
383800
$472.54M
721.19B KRW
2K%
5.3
Industry: Financial Conglomerates (Global)
Name
Market Cap diff.
PE
INVE-A
$120.24B
1.14T SEK
411K%
5.9
ITSA3
$30.32B
157.1B BRL
104K%
9.5
$21.98B
207.94B SEK
75K%
5.2
$18.92B
598.03B TWD
65K%
12.6
HAL
$17.78B
15.4B EUR
61K%
9.6
$17.36B
1.66T INR
59K%
101.9
chevron_leftBack